Larvol Delta - Coya-Therapeutics-Expands-Pipeline-and-Intellectual-Property-Portfolio-with-Filing-of-New-US-Patents-for-COYA-301-in-Combination-with-GlucagonLike-Peptide1-GLP1-Receptor-Agonists

COYA 301 - Coya Therap

https://www.businesswire.com/news/home/20240731277398/en/Coya-Therapeutics-Expands-Pipeline-and-Intellectual-Property-Portfolio-with-Filing-of-New-U.S.-Patents-for-COYA-301-in-Combination-with-Glucagon-Like-Peptide-1-GLP-1-Receptor-Agonists

Jul 31, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next